Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production

 Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production

(marketscreener.com)
Phylos is a recognized leader in seed genetics with a growing IP portfolio including the highest potency THCV cultivars available

Organigram will launch new products in Canada containing THCV, a novel and rare cannabinoid referred to …

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has reached agreement with Phylos Bioscience Inc. …